Taking the challenge: A protocolized approach to optimize Pneumocystis pneumonia prophylaxis in renal transplant recipients
暂无分享,去创建一个
E. Phillips | F. Ierino | J. Trubiano | P. Mount | A. Mahony | K. Urbancic
[1] F. Ierino,et al. Is Aerosolized Pentamidine for Pneumocystis Pneumonia Prophylaxis in Renal Transplant Recipients Not as Safe as We Might Think? , 2016, Antimicrobial Agents and Chemotherapy.
[2] A. Cheng,et al. The prevalence and impact of antimicrobial allergies and adverse drug reactions at an Australian tertiary centre , 2015, BMC Infectious Diseases.
[3] G. Marshall,et al. Antibiotic hypersensitivity reactions and approaches to desensitization. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] D. Brennan,et al. Benefits of sulfamethoxazole‐trimethoprim prophylaxis on rates of sepsis after kidney transplant , 2014, Transplant infectious disease : an official journal of the Transplantation Society.
[5] R. Middleton,et al. Complications and outcomes of trimethoprim–sulphamethoxazole as chemoprophylaxis for pneumocystis pneumonia in renal transplant recipients , 2014, Nephrology.
[6] James T.C. Li,et al. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction. , 2014, The journal of allergy and clinical immunology. In practice.
[7] J. Fishman,et al. Pneumocystis Pneumonia in Solid Organ Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] P. Martín-Dávila,et al. Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] E. Cavalier,et al. Trimethoprim, Creatinine and Creatinine-Based Equations , 2011, Nephron Clinical Practice.
[10] F. Oppenheimer,et al. Toxoplasma gondii primary infection in renal transplant recipients. Two case reports and literature review , 2011, Transplant international : official journal of the European Society for Organ Transplantation.
[11] Sally Haack,et al. Knowledge and attitudes of American pharmacists concerning sulfonamide allergy cross-reactivity , 2010, Pharmacy World & Science.
[12] W. Pichler,et al. Cross-Reactivity in Drug Hypersensitivity Reactions to Sulfasalazine and Sulfamethoxazole , 2010, International Archives of Allergy and Immunology.
[13] D. O'Donovan,et al. Usage and cost of a nebulised pentamidine clinic in a large teaching hospital. , 2009, The Journal of infection.
[14] L. Leibovici,et al. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. , 2014, The Cochrane database of systematic reviews.
[15] J. Fishman. Infection in solid-organ transplant recipients. , 2007, The New England journal of medicine.
[16] M. Rieder,et al. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole. , 2007, The Cochrane database of systematic reviews.
[17] Sean Hennessy,et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. , 2003, The New England journal of medicine.
[18] P. Ubel,et al. Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole. , 1996, The American journal of medicine.
[19] D. Cooper,et al. Patterns of multiple‐drug hypersensitivities in HIV‐infected patients , 1993, AIDS.
[20] D. Cooper,et al. Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients. , 1993, AIDS.
[21] D. Davies,et al. Textbook of Adverse Drug Reactions , 1992, Annals of Internal Medicine.